The science behind the system
Havas Health & You introduces Havas ECS (Endocannabinoid Science), a strategic communications advisory and education company focused on the importance and value of foundational scientific knowledge of the endocannabinoid system, to better guide and better inform improved decision making on ECS-related topics.
Fueled by deep subject matter expertise, and a network of medical advisors skilled in the application of cannabinoid medicine, Havas ECS helps clients seeking a science-based approach to their communications needs.
Join us in New York City!
November 15, 2019
Alfred Lerner Hall
2920 Broadway, Columbia University, New York, NY
Medical Cannabis: The science. The research. The risks. 2019 is the industry’s premier cannabinoid education conference, offering foundational knowledge from global experts in the science, usage, and potential liabilities surrounding the medical cannabis revolution.
Speakers will include:
VP Patient Research and Access at Tilray
Dr. Margaret Haney,
Professor of Neurobiology (in Psychiatry)
at Columbia University Medical Center
Dr. Jahan Marcu,
Editor-in-Chief of the American Journal of Endocannabinoid Medicine,
CSO International Research Center on Cannabis and Health
Lauren A. Rudick,
Attorney and Member at Hiller, PC, New York
Fatima V. Afia, Esq.,
Attorney at Hiller, PC, New York
Former NFL Star, Executive at Isodiol
Arm yourself with the best and most accurate information available.
Therapeutic areas where cannabinoid
therapies are being researched
- • Alzheimer’s disease
- • Anorexia
- • Autism spectrum disorders
- • Autoimmune disease and inflammation
- • Bladder dysfunction
- • Cancer
- • Chronic pain
- • Epilepsy
- • Fragile X syndrome
- • Glaucoma
- • Insomnia
- • Migraine
- • Multiple sclerosis
- • Neonatal hypoxic-ischemic encephalopathy
- • Neuropathy (neuropathic pain)
- • Schizophrenia
- • Spinal cord injury
Havas ECS: Experience
Rob is an experienced communications executive, healthcare strategist, and leader of cross‑functional teams. Rob and his Havas team serve to advance the understanding of cannabinoid health and wellness, with science‑based education and communication programs that frame and elevate the cannabinoid conversation, and increase understanding of cannabinoid treatments and ECS‑related medical conditions.
Rob Dhoble, Managing Director